Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 486

1.

Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide.

Martin-Suarez I, D'Cruz D, Mansoor M, Fernandes AP, Khamashta MA, Hughes GR.

Ann Rheum Dis. 1997 Aug;56(8):481-7.

2.
3.

Substitution of methotrexate for cyclophosphamide in Wegener granulomatosis: a 12-year single-practice experience.

Villa-Forte A, Clark TM, Gomes M, Carey J, Mascha E, Karafa MT, Roberson G, Langford CA, Hoffman GS.

Medicine (Baltimore). 2007 Sep;86(5):269-77.

4.

The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.

Tangnararatchakit K, Tapaneya-Olarn C, Tapaneya-Olarn W.

J Med Assoc Thai. 1999 Nov;82 Suppl 1:S104-10.

PMID:
10730528
5.

[Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].

Petrović R, Stojanović R, Novicić-Sasić D, Dimitrijević J, Pavlović S, Stojković D, Palić-Obradović D, Stevanović G, Prodanović S.

Srp Arh Celok Lek. 2002 Aug;130 Suppl 3:19-25. Serbian.

PMID:
12583309
6.

[Treatment of acute systemic lupus erythematosus with intravenous infusions of cyclophosphamide. Value and limitations].

De Bandt M, Goycochea MV, Meyer O, Delahousse M, Palazzo E, M'Bappé P, Kahn MF.

Ann Med Interne (Paris). 1994;145(2):75-87. French.

PMID:
8024184
7.

Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides.

Gayraud M, Guillevin L, Cohen P, Lhote F, Cacoub P, Deblois P, Godeau B, Ruel M, Vidal E, Piontud M, Ducroix JP, Lassoued S, Christoforov B, Babinet P.

Br J Rheumatol. 1997 Dec;36(12):1290-7.

PMID:
9448590
8.

[Treatment of systemic diseases with pulse cyclophosphamide: 15 cases].

Amoura Z, Choukroun G, Royer I, Gayraud M, Guillevin L.

Ann Med Interne (Paris). 1990;141(5):416-20. Review. French.

PMID:
2256584
9.

Treatment of systemic vasculitis with cyclophosphamide and steroids: daily oral low-dose cyclophosphamide administration after failure of a pulse intravenous high-dose regimen in four patients.

Généreau T, Lortholary O, Leclerq P, Grenet D, Tubéry M, Sicard D, Caubarrère I, Guillevin L.

Br J Rheumatol. 1994 Oct;33(10):959-62.

PMID:
7921758
10.

Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide.

Hari P, Bagga A, Jindal N, Srivastava RN.

Pediatr Nephrol. 2001 Nov;16(11):901-5.

PMID:
11685598
11.

[Intravenous cyclophosphamide in lupus nephritis: twenty years reducing dose].

Frutos MA, Martín Gómez A, de Ramón E, Camps MT, Valera A, García I, Fernández Nebro A.

Nefrologia. 2007;27(1):12-22. Spanish.

12.
13.

B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study.

Martinez Del Pero M, Chaudhry A, Jones RB, Sivasothy P, Jani P, Jayne D.

Clin Otolaryngol. 2009 Aug;34(4):328-35. doi: 10.1111/j.1749-4486.2009.01968.x.

PMID:
19673980
14.

Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis.

Adu D, Pall A, Luqmani RA, Richards NT, Howie AJ, Emery P, Michael J, Savage CO, Bacon PA.

QJM. 1997 Jun;90(6):401-9.

PMID:
9205678
15.

Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.

Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R.

Arthritis Rheum. 2002 Aug;46(8):2121-31.

16.

Prolonged treatment with low-dose intravenous pulse cyclophosphamide may reduce rate of relapse in ANCA-associated vasculitis.

Dhaygude A, Griffith M, Cairns T, McLean A, Palmer A, Taube D.

Nephron Clin Pract. 2004;97(4):c154-9. Review.

PMID:
15331939
17.

Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide.

Hoffman GS, Leavitt RY, Fleisher TA, Minor JR, Fauci AS.

Am J Med. 1990 Oct;89(4):403-10.

PMID:
2220874
18.

Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients.

Huong DL, Amoura Z, Duhaut P, Sbai A, Costedoat N, Wechsler B, Piette JC.

J Rheumatol. 2002 Dec;29(12):2571-6.

PMID:
12465154
19.

Wegener's granulomatosis: long-term follow-up of patients treated with pulse cyclophosphamide.

Koldingsnes W, Gran JT, Omdal R, Husby G.

Br J Rheumatol. 1998 Jun;37(6):659-64.

PMID:
9667621
20.

Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis.

Illei GG, Yarboro CH, Kuroiwa T, Schlimgen R, Austin HA, Tisdale JF, Chitkara P, Fleisher T, Klippel JH, Balow JE, Boumpas DT.

Rheumatology (Oxford). 2007 Jun;46(6):952-6. Epub 2007 Feb 22.

PMID:
17317716

Supplemental Content

Support Center